close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Peter Maslak

location-icon

Buffalo, NY

LOCATION OF PRACTICE
Memorial Sloan Kettering Cancer Center
MEDICAL Specialty:

Chronic Myeloid Leukemia (cml), Non-hodgkin's Lymphoma, Osteosarcoma



ELM AND CARLTON ST, BUFFALO, NY, 142630001
ELM AND CARLTON ST, BUFFALO, NY, 142630001
716-845-2300
NPI Number
1265403067
ABOUT

Peter Maslak, MD, is a hematologist in New York, NY. He has 41 years of experience and is board certified in hematology. Maslak graduated from City University of New York School of Medicine and is affiliated with Memorial Sloan Kettering Cancer Center.

Dr. Peter Maslak profile image

Published Articles

Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.- 2026 Feb
Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.- 2024 Aug
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.- 2024 May
Biological Activity of Extracts from Differently Produced Blueberry Fruits in Inhibiting Proliferation and Inducing Apoptosis of HT-29 Cells.- 2022 Sep 28
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.- 2022 May 13
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.- 2022 May 5
Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies.- 2022 Jan
CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer.- 2021 Jul
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.- 2021 Aug
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.- 2021 Aug 19

Clinical Trials

Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Other Specialists treating Chronic Myeloid Leukemia (CML), Non-Hodgkin's Lymphoma, Osteosarcoma in Buffalo, NY

See All Doctors

Dr. Paola Ghione

Specialty: Marginal Zone Lymphoma, Non-Hodgkin's Lymphoma, Hodgkin's Disease

My Resources
location-icon

Boca Raton Regional Hospital

My Resources

Dr. Dorothy Pan

Specialty: Diffuse Large B-Cell Lymphoma, Primary Central Nervous System Lymphoma, Non-Hodgkin's Lymphoma

My Resources
location-icon

Auburn Community Hospital

My Resources

Dr. Maureen Ross

Specialty: Acute Lymphoid Leukemia, Acute Leukemia, Osteosarcoma

My Resources
location-icon

Aurelia Osborn Fox Memorial Hospital

My Resources

Dr. Francisco Hernandez

Specialty: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma

My Resources
location-icon

Ira Davenport Memorial Hospital

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider